Ginkgo Bioworks Holdings, Inc., a Delaware corporation, filed a Form S-3 registration statement with the Securities and Exchange Commission (SEC) on May 9, 2024. The filing pertains to the resale or disposition of up to 18,857,026 shares of Class A common stock by selling securityholders, which includes entities such as AgBiome, Inc. The shares may be sold from time to time in a variety of methods, including on stock exchanges, in private transactions, or through broker-dealers. Ginkgo Bioworks will not receive any proceeds from the sale of these shares. The registration statement also includes provisions for indemnification of officers and directors, the company's capital stock description, and the appointment of powers of attorney. The selling securityholders may include donees, pledgees, or other transferees who receive shares after the prospectus date. The registration allows these parties to resell their shares publicly.

Ginkgo Bioworks Holdings, Inc., a Delaware corporation, filed a Form S-3 registration statement with the Securities and Exchange Commission (SEC) on May 9, 2024. The filing pertains to the resale or disposition of up to 18,857,026 shares of Class A common stock by selling securityholders, which includes entities such as AgBiome, Inc. The shares may be sold from time to time in a variety of methods, including on stock exchanges, in private transactions, or through broker-dealers. Ginkgo Bioworks will not receive any proceeds from the sale of these shares. The registration statement also includes provisions for indemnification of officers and directors, the company's capital stock description, and the appointment of powers of attorney. The selling securityholders may include donees, pledgees, or other transferees who receive shares after the prospectus date. The registration allows these parties to resell their shares publicly.